Week of April 23 - 29, 2017
Take our short survey and help us plan future projects!
Niraparib is a PARP inhibitor used in the treatment of ovarian, fallopian tube, endometrial and primary peritoneal cancers.
Avelumab (Bavenicio ®) is a programmed death ligand-1 (PD-L1) blocking antibody used in the treatment of Merkel cell carcinoma.
Telotristat (Xermelo™) is a tryptophan hydroxylase inhibitor used to treat diarrhea related to carcinoid syndrome.
Ribociclib (Kisquali®) is used in the treatment of hormone receptor positive, HER2 negative, advanced or metastatic breast cancer in post-menopausal women.
First bite syndrome is a side effect of some head and neck cancer tumors or treatments that causes mouth pain when salivating or taking the first couple bites of food.
Cervical dystonia is a side effect which causes neck muscles to contract on their own causing abnormal movements and abnormal posture of the head and neck.
Lanreotide is similar to a hormone that occurs naturally in the body and is used to treat carcinoid syndrome.
Radiation fibrosis syndrome is a common late side effect of radiation in the treatment of head and neck cancer.
Information about the side effect trismus and how it is treated.
Information about Spinal Accessory Nerve Palsy, a side effect of some treatments for head and neck cancers.
This webinar provides an introduction to the treatment of head and neck cancers, with a focus on radiation therapy and specifically the treatment of head and neck cancers with proton therapy.
PTLDs are a type of lymphoma that are a complication of both solid organ and allogeneic bone marrow or stem cell transplants.
Information about dental care specifically for head and neck cancer survivors.
Provides support and coping information for body image changes during and after head and neck cancer treatment.